Miruna has more than 20 years of experience at leading life science organizations such as Johnson & Johnson and Bristol-Myers Squibb. Most recently, Miruna was serving as the head of Johnson & Johnson’s Clinical Trial Feasibility and Advanced Analytics team where she drove global adoption of integrated real-world data and innovation strategies across several therapeutic areas.
Miruna is an accomplished executive with a track record of success when it comes to driving broad-based digital innovation. Miruna brings deep experience in the utilization and scaling of emerging innovations to advance drug portfolios. She also has both a Ph.D. in biology and statistics, and a master’s in business administration.
With decades of in-house life science experience, Miruna’s guidance and collaboration will prove invaluable to COTA clients that are looking to drive innovation and accelerate availability of much-needed cancer drugs and therapies through the adoption and at-scale use of real-world data.
In her new role as Chief Strategy Officer, Life Sciences, Miruna will play a critical role in setting the strategy and executing the solutions delivery to meet critical needs in partnership with life science companies to drive efficient and optimal drug development.